2012

Tolmachev V, Tran T A, Rosik D, Sjöberg A, Abrahmsén L, Orlova A.
Tumor Targeting Using Affibody Molecules: Interplay of Affinity, Target Expression Level, and Binding Site Composition.
The Journal Of Nuclear Medicine, 2012 vol. 53 no. 6.

Madru R, Kjellman P, Olsson F, Wingårdh K, Ingvar C, Ståhlberg F, Olsrud J, Lätt J, Fredriksson S, Knutsson L, Strand SE.
99mTc-Labeled Superparamagnetic Iron Oxide Nanoparticles for Multimodality SPECT/MRI of Sentinel Lymph Nodes.
J Nucl Med March 1, 2012 vol. 53 no. 3 459-46.

2011

Tran T A, Kirik D.
Imaging of Brain Prion Protein amyloid in Patients with Gertstmann-Sträussler-Scheinker Disease.
Zdravniški vestnik / Slovenian Medical Journal, 2011 vol. 80 no. 12, 969 - 970

Moser E, Stahlberg F, Ladd ME, Trattnig S.
7-T MR-from research to clinical applications?
NMR Biomed. 2011 Nov 21. [Epub ahead of print]

Hall H, Cuellar-Baena S, Dahlberg C, In't Zandt R, Denisov V, Kirik D.
Magnetic Resonance Spectroscopic Methods for the Assessment of Metabolic Functions in the Diseased Brain.
Curr Top Behav Neurosci. 2011 Nov 11. [Epub ahead of print]

Qvarnström OF, Simonsson M, Carlsson J, Tran TA.
Effects of affinity on binding of HER2-targeting Affibody molecules: model experiments in breast cancer spheroids.
Int J Oncol. 2011 Aug;39(2):353-9.

Siikanen J, Ohlsson T, Sandell A, Strand SE, Tran TA.
Labeling proteins with 89Zr separated from large yttrium bulks.
J Nucl Med. 2011; 52 (Supplement 1):1504

2010

Cudalbu C, Comment A, Kurdzesau F, van Heeswijk RB, Uffmann K, Jannin S, Denisov V, Kirik D, Gruetter R.
Feasibility of in vivo 15N MRS detection of hyperpolarized 15N labeled choline in rats. 
Phys Chem Chem Phys. 2010 Jun 14;12(22):5818-23.

2009

Sarkar R, Comment A, Vasos PR, Jannin S, Gruetter R, Bodenhausen G, Hall H, Kirik D, Denisov VP.
Proton NMR of (15)N-choline metabolites enhanced by dynamic nuclear polarization.
J Am Chem Soc. 2009 Nov 11;131(44):16014-5.